Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.

Name: Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.
Author: Gillies, Mark C

Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial. — المؤلف: Gillies, Mark C — JAMA ophthalmology 20200302

المؤلف: Gillies, Mark C
النشر: JAMA ophthalmology 20200302
الوصف: 372-379 p.
الموضوعات: Aged؛ Aged, 80 and over؛ Angiogenesis Inhibitors؛ Dose-Response Relationship, Drug؛ Female؛ Fluorescein Angiography؛ Fundus Oculi؛ Humans